FDA Advisory Committee Meeting Cancellation

The U.S. Food and Drug Administration (FDA) unexpectedly canceled a scheduled meeting of the Vaccines and Related Biological Products Advisory Committee (VRBPAC), which is responsible for selecting flu strains for the upcoming season's vaccine. The reason for the cancellation has not been disclosed, raising concerns about potential delays in vaccine formulation and effectiveness.